Skip to main content
$48.00 -$0.26 (-0.5%)

04:00 PM EST on 11/29/22

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

CAPS Rating: 4 out of 5

Current Price $48.00 Mkt Cap $3.8B
Open $48.74 P/E Ratio 0.00
Prev. Close $48.00 Div. (Yield) $0.00 (0.0%)
Daily Range $47.23 - $49.62 Volume 625,989
52-Wk Range $37.08 - $130.33 Avg. Daily Vol. 850,757

Caps

How do you think NASDAQ:NTLA will perform against the market?

Add Stock to CAPS Watchlist

All Players

127 Outperform
4 Underperform
 

All-Star Players

17 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NTLA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFRetireFoolish (< 20)
Submitted July 08, 2021

CRSPR in vivo success would position for many new therapies and industry leadership

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:NTLA Summary

Fools bullish on NASDAQ:NTLA are also bullish on:

Fools bearish on NASDAQ:NTLA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NTLA.

Recs

0
Member Avatar TMFSecurity (94.46) Submitted: 11/16/2021 8:22:40 AM : Underperform Start Price: $132.82 NASDAQ:NTLA Score: +48.47

10000000146

Recs

2
Member Avatar TMFRetireFoolish (< 20) Submitted: 7/8/2021 1:22:52 AM : Outperform Start Price: $151.10 NASDAQ:NTLA Score: -60.41

CRSPR in vivo success would position for many new therapies and industry leadership

Recs

3
Member Avatar TMFbonefish (37.50) Submitted: 5/5/2021 5:06:08 PM : Outperform Start Price: $72.96 NASDAQ:NTLA Score: -29.26

It's hard not to imagine gene-editing as the future of medicine. The company has about $600 million in cash and short-term investments on its balance sheet, and recently received funding from the Bill & Melinda Gates Foundation. That cash cushion is important. Even if the company eventually delivers a treatment or treatments that lead to commercial success, that won't happen for a least a few years. For investors, therefore, owning Intellia stock requires a leap of faith.

Leaderboard

Find the members with the highest scoring picks in NTLA.

Score Leader

allforone

allforone (77.92) Score: +935.97

The Score Leader is the player with the highest score across all their picks in NTLA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
birdup < 20 3/16/2020 Outperform 5Y $9.87 +386.32% +64.00% +322.32 0 Comment
Playa14 < 20 10/17/2019 Outperform 5Y $11.40 +321.05% +32.27% +288.78 0 Comment
TraderEnvy < 20 10/4/2019 Outperform 5Y $11.94 +302.01% +35.68% +266.33 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Kevinkress < 20 5/4/2020 Outperform 5Y $13.09 +266.69% +40.80% +225.90 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. ldigout 74.08 4/13/2020 Outperform 5Y $13.05 +267.82% +42.50% +225.32 0 Comment
clangmead 43.63 12/28/2018 Outperform 5Y $12.51 +283.69% +58.97% +224.72 0 Comment
3dw4rdN1gm4 38.99 2/5/2020 Outperform 5Y $14.20 +238.03% +19.35% +218.68 0 Comment
k3ythd4vid 46.06 2/5/2020 Outperform 5Y $14.20 +238.03% +19.48% +218.54 0 Comment
CMFMLove 33.79 6/13/2017 6/23/2022 Outperform NS $12.67 +278.85% +61.99% +216.85 1 Comment
ZabasJ < 20 4/21/2020 Outperform 5Y $13.33 +260.08% +44.00% +216.08 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NTLA.